Actinium Pharmaceuticals, Inc. (ATNM)

1.780.01 (-0.56%)

Actinium Pharmaceuticals, Inc. (ATNM) stock comprehensive Balance Sheet Growth Analysis including assets, liabilities, and equity growth. Compare balance sheet against peers/competitors, industry and sector standards.

High Bankruptcy RiskBelow Average ESGFair ValuationLow ProfitabilityAdequate Financial HealthInefficient OperationsModerate GrowthLow QualityAdequate Dividend ProfileIndustry Rank: 20.71%Sector Rank: 20.23%

AMEX - Healthcare - Biotechnology | Market Cap: 55.53M | Next Earnings Date: 13 Nov 2025

Day's Range

1.75 - 1.81

52-Week Range

1.03 - 2.41

Volume

122.5K / 296.7K (Avg.)

P/E Ratio | EPS

-1.36 | -1.31

Trending:

ATNM Balance Sheet Growth Analysis

Compare against a Competitor

None AGEN AVXL RVPH AXSM TRAW

Identifies how quickly the company is scaling its balance sheet (via acquisitions, expansions, or debt). Strong growth, accompanied by sound fundamentals, can support long-term intrinsic value—while disproportionate debt expansion or bloated intangible assets can signal elevated risk.

Cash & Equivalents Growth

-7.59%

Increased from previous period

Cash & equivalents declining -7.59% while Healthcare shows 0.00% growth. Howard Marks would investigate if this cash drain is temporary or signals deeper issues.

Short-Term Investments Growth

No Data

No Data available this quarter, please select a different quarter.

Cash + Short-Term Investments Growth

-7.59%

Increased from previous period

Below half the Healthcare median of 0.00% yoy growth. Jim Chanos might see inadequate liquidity buildup relative to peers. Verify free cash flow trends.

Net Receivables Growth

No Data

No Data available this quarter, please select a different quarter.

Inventory Growth

No Data

No Data available this quarter, please select a different quarter.

Other Current Assets Growth

-100.00%

Decreased from previous period

Exceeding 1.5x Healthcare median of 0.00%. Jim Chanos might suspect questionable capitalization or one-time items inflating current assets.

Total Current Assets Growth

-8.57%

Increased from previous period

Below half the Healthcare median of 0.00%. Jim Chanos would question if the company faces working capital strain.

PP&E (Net) Growth

-5.56%

Decreased from previous period

PP&E growth below half of Healthcare median of 0.00%. Jim Chanos would suspect potential underinvestment or strategic shift away from core assets.

Goodwill Growth

No Data

No Data available this quarter, please select a different quarter.

Intangible Assets Growth

No Data

No Data available this quarter, please select a different quarter.

Goodwill + Intangibles Growth

No Data

No Data available this quarter, please select a different quarter.

Long-Term Investments Growth

0.97%

Decreased from previous period

≥ 1.5x the Healthcare median of 0.00%. Joel Greenblatt sees a bigger push into long-term investments. Check synergy with core business.

Tax Assets Growth

No Data

No Data available this quarter, please select a different quarter.

Other Non-Current Assets Growth

No Data

No Data available this quarter, please select a different quarter.

Total Non-Current Assets Growth

-4.96%

Decreased from previous period

Below half the Healthcare median of 0.00%. Jim Chanos sees a sharp divergence from peers, possibly a sign of strategic retreat or capital shortage.

Other Assets Growth

No Data

No Data available this quarter, please select a different quarter.

Total Assets Growth

-8.43%

Increased from previous period

Below half the Healthcare median of 0.00%. Jim Chanos might see potential stagnation or distress vs. peers.

Accounts Payable Growth

-2.42%

Increased from previous period

Payables growth above 1.5x Healthcare median of 0.00%. Jim Chanos might see a warning sign of stressed supplier payments.

Short-Term Debt Growth

3.64%

Increased from previous period

Above 1.5x Healthcare median of 0.00%. Jim Chanos might see a short-term leverage spike, raising red flags for near-term solvency.

Tax Payables Growth

No Data

No Data available this quarter, please select a different quarter.

Deferred Revenue (Current) Growth

-101.55%

Below half Healthcare median of 0.00%. Jim Chanos sees a potential sales pipeline shortfall.

Other Current Liabilities Growth

-3.64%

Decreased from previous period

Above 1.5x Healthcare median of 0.00%. Jim Chanos suspects a potential short-term burden spike.

Total Current Liabilities Growth

-2.05%

Increased from previous period

Below half Healthcare median of 0.75%. Joel Greenblatt sees more conservative short-term leverage than peers.

Long-Term Debt Growth

No Data

No Data available this quarter, please select a different quarter.

Non-Current Deferred Revenue Growth

No Data

No Data available this quarter, please select a different quarter.

Deferred Tax Liabilities (Non-Current) Growth

95.51%

Above 1.5x Healthcare median of 0.00%. Jim Chanos suspects major expansions in deferred taxes.

Other Non-Current Liabilities Growth

No Data

No Data available this quarter, please select a different quarter.

Total Non-Current Liabilities Growth

-0.32%

Increased from previous period

Above 1.5x Healthcare median of 0.00%. Jim Chanos suspects a red flag in ballooning future obligations.

Other Liabilities Growth

No Data

No Data available this quarter, please select a different quarter.

Total Liabilities Growth

-0.65%

Increased from previous period

Below half Healthcare median of 0.31%. Joel Greenblatt sees a much lower liability expansion vs. peers.

Common Stock (Book Value) Growth

3.70%

Above 1.5x Healthcare median of 0.00%. Jim Chanos suspects heavier share issuance than peers.

Retained Earnings Growth

-2.84%

Increased from previous period

≥ 1.5x Healthcare median of -1.29%. Joel Greenblatt sees stronger retained profit growth vs. peers.

AOCI Growth

No Data

No Data available this quarter, please select a different quarter.

Other Stockholders' Equity Items Growth

No Data

No Data available this quarter, please select a different quarter.

Total Stockholders' Equity Growth

-16.53%

Increased from previous period

Below half Healthcare median of 0.00%. Jim Chanos suspects slower net worth growth or losses vs. peers.

Liabilities + Equity Growth

-8.43%

Increased from previous period

Below half Healthcare median of 0.00%. Jim Chanos suspects a major slowdown or distress.

Total Investments Growth

0.97%

Decreased from previous period

≥ 1.5x Healthcare median of 0.00%. Joel Greenblatt sees bigger push into investments vs. peers.

Total Debt Growth

-4.43%

Increased from previous period

Above 1.5x Healthcare median of 0.00%. Jim Chanos suspects a big rise in leverage. Check coverage carefully.

Net Debt Growth

7.68%

Decreased from previous period

Above 1.5x Healthcare median 0.70%. Jim Chanos sees a big jump in net debt. Potential leverage red flag.

+ Add New Metric (Coming Soon)

Add more metric or remove existing ones, customize as per your preference, feature coming soon!

Select Chart Metric:

ATNM Balance Sheet Growth Analysis

Compare against a Competitor

None AGEN AVXL RVPH AXSM TRAW

Cash & Equivalents Growth

-7.59%

Increased from previous period

Cash & equivalents declining -7.59% while Healthcare shows 0.00% growth. Howard Marks would investigate if this cash drain is temporary or signals deeper issues.

Short-Term Investments Growth

No Data

No Data available this quarter, please select a different quarter.

Cash + Short-Term Investments Growth

-7.59%

Increased from previous period

Below half the Healthcare median of 0.00% yoy growth. Jim Chanos might see inadequate liquidity buildup relative to peers. Verify free cash flow trends.

Net Receivables Growth

No Data

No Data available this quarter, please select a different quarter.

Inventory Growth

No Data

No Data available this quarter, please select a different quarter.

Other Current Assets Growth

-100.00%

Decreased from previous period

Exceeding 1.5x Healthcare median of 0.00%. Jim Chanos might suspect questionable capitalization or one-time items inflating current assets.

Total Current Assets Growth

-8.57%

Increased from previous period

Below half the Healthcare median of 0.00%. Jim Chanos would question if the company faces working capital strain.

PP&E (Net) Growth

-5.56%

Decreased from previous period

PP&E growth below half of Healthcare median of 0.00%. Jim Chanos would suspect potential underinvestment or strategic shift away from core assets.

Goodwill Growth

No Data

No Data available this quarter, please select a different quarter.

Intangible Assets Growth

No Data

No Data available this quarter, please select a different quarter.

Goodwill + Intangibles Growth

No Data

No Data available this quarter, please select a different quarter.

Long-Term Investments Growth

0.97%

Decreased from previous period

≥ 1.5x the Healthcare median of 0.00%. Joel Greenblatt sees a bigger push into long-term investments. Check synergy with core business.

Tax Assets Growth

No Data

No Data available this quarter, please select a different quarter.

Other Non-Current Assets Growth

No Data

No Data available this quarter, please select a different quarter.

Total Non-Current Assets Growth

-4.96%

Decreased from previous period

Below half the Healthcare median of 0.00%. Jim Chanos sees a sharp divergence from peers, possibly a sign of strategic retreat or capital shortage.

Other Assets Growth

No Data

No Data available this quarter, please select a different quarter.

Total Assets Growth

-8.43%

Increased from previous period

Below half the Healthcare median of 0.00%. Jim Chanos might see potential stagnation or distress vs. peers.

Accounts Payable Growth

-2.42%

Increased from previous period

Payables growth above 1.5x Healthcare median of 0.00%. Jim Chanos might see a warning sign of stressed supplier payments.

Short-Term Debt Growth

3.64%

Increased from previous period

Above 1.5x Healthcare median of 0.00%. Jim Chanos might see a short-term leverage spike, raising red flags for near-term solvency.

Tax Payables Growth

No Data

No Data available this quarter, please select a different quarter.

Deferred Revenue (Current) Growth

-101.55%

Below half Healthcare median of 0.00%. Jim Chanos sees a potential sales pipeline shortfall.

Other Current Liabilities Growth

-3.64%

Decreased from previous period

Above 1.5x Healthcare median of 0.00%. Jim Chanos suspects a potential short-term burden spike.

Total Current Liabilities Growth

-2.05%

Increased from previous period

Below half Healthcare median of 0.75%. Joel Greenblatt sees more conservative short-term leverage than peers.

Long-Term Debt Growth

No Data

No Data available this quarter, please select a different quarter.

Non-Current Deferred Revenue Growth

No Data

No Data available this quarter, please select a different quarter.

Deferred Tax Liabilities (Non-Current) Growth

95.51%

Above 1.5x Healthcare median of 0.00%. Jim Chanos suspects major expansions in deferred taxes.

Other Non-Current Liabilities Growth

No Data

No Data available this quarter, please select a different quarter.

Total Non-Current Liabilities Growth

-0.32%

Increased from previous period

Above 1.5x Healthcare median of 0.00%. Jim Chanos suspects a red flag in ballooning future obligations.

Other Liabilities Growth

No Data

No Data available this quarter, please select a different quarter.

Total Liabilities Growth

-0.65%

Increased from previous period

Below half Healthcare median of 0.31%. Joel Greenblatt sees a much lower liability expansion vs. peers.

Common Stock (Book Value) Growth

3.70%

Above 1.5x Healthcare median of 0.00%. Jim Chanos suspects heavier share issuance than peers.

Retained Earnings Growth

-2.84%

Increased from previous period

≥ 1.5x Healthcare median of -1.29%. Joel Greenblatt sees stronger retained profit growth vs. peers.

AOCI Growth

No Data

No Data available this quarter, please select a different quarter.

Other Stockholders' Equity Items Growth

No Data

No Data available this quarter, please select a different quarter.

Total Stockholders' Equity Growth

-16.53%

Increased from previous period

Below half Healthcare median of 0.00%. Jim Chanos suspects slower net worth growth or losses vs. peers.

Liabilities + Equity Growth

-8.43%

Increased from previous period

Below half Healthcare median of 0.00%. Jim Chanos suspects a major slowdown or distress.

Total Investments Growth

0.97%

Decreased from previous period

≥ 1.5x Healthcare median of 0.00%. Joel Greenblatt sees bigger push into investments vs. peers.

Total Debt Growth

-4.43%

Increased from previous period

Above 1.5x Healthcare median of 0.00%. Jim Chanos suspects a big rise in leverage. Check coverage carefully.

Net Debt Growth

7.68%

Decreased from previous period

Above 1.5x Healthcare median 0.70%. Jim Chanos sees a big jump in net debt. Potential leverage red flag.

+ Add New Metric (Coming Soon)

Add more metric or remove existing ones, customize as per your preference, feature coming soon!

Select Chart Metric: